Brexpiprazole in the Management of Schizophrenia: A Consensus Report of Best Practices From Acute to Maintenance Treatment.

Correll CU, Mafi CE, Fagiolini A, Seerden P, Seifritz E, Tiihonen J, Vita A, Citrome L

Open source

DOI
10.2147/ndt.s539306
Published
2025
Container
Neuropsychiatric disease and treatment
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.2147/ndt.s539306,
  title = {Brexpiprazole in the Management of Schizophrenia: A Consensus Report of Best Practices From Acute to Maintenance Treatment.},
  author = {Correll CU and Mafi CE and Fagiolini A and Seerden P and Seifritz E and Tiihonen J and Vita A and Citrome L},
  year = {2025},
  journal = {Neuropsychiatric disease and treatment},
  doi = {10.2147/ndt.s539306},
  url = {https://doi.org/10.2147/ndt.s539306}
}

RIS

TY  - JOUR
TI  - Brexpiprazole in the Management of Schizophrenia: A Consensus Report of Best Practices From Acute to Maintenance Treatment.
AU  - Correll CU
AU  - Mafi CE
AU  - Fagiolini A
AU  - Seerden P
AU  - Seifritz E
AU  - Tiihonen J
AU  - Vita A
AU  - Citrome L
PY  - 2025
JO  - Neuropsychiatric disease and treatment
DO  - 10.2147/ndt.s539306
UR  - https://doi.org/10.2147/ndt.s539306
ER  - 

APA

CU, C., CE, M., A, F., P, S., E, S., J, T., A, V., & L, C. (2025). Brexpiprazole in the Management of Schizophrenia: A Consensus Report of Best Practices From Acute to Maintenance Treatment.. Neuropsychiatric disease and treatment. https://doi.org/10.2147/ndt.s539306

Source records